Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent
NCT03318796 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 335
Last updated 2019-02-26
Summary
TRYTON Post Approval Study (PAS) of the Tryton Side Branch Stent
Conditions
Interventions
- DEVICE
-
Coronary Artery Stenting
Interventional coronary artery stent placement in De novo bifurcation lesions of the MB \& SB
Sponsors & Collaborators
-
Tryton Medical, Inc.
lead INDUSTRY
Principal Investigators
-
Joel Schnieder, MD · Rex Health; Raleigh NC
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-22
- Primary Completion
- 2019-12-30
- Completion
- 2022-12-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent
NCT02328898 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 ·Status: UNKNOWN
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions
NCT04830228 ·Status: ACTIVE_NOT_RECRUITING
-
The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting
NCT01534221 ·Status: UNKNOWN ·Phase: PHASE4
-
The Direct III Post Market Study
NCT02693158 ·Status: COMPLETED
-
An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
NCT01638507 ·Status: COMPLETED ·Phase: NA
-
A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
NCT04179045 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
NCT01489449 ·Status: COMPLETED ·Phase: PHASE4
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651 ·Status: RECRUITING ·Phase: NA
-
Antiplatelet Therapy Following Stent Implantation
NCT02051361 ·Status: COMPLETED
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
NCT01811927 ·Status: TERMINATED ·Phase: NA
-
Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries
NCT00732953 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4
-
PROGRESS-AMS 1.0 Clinical Long Term Follow-Up
NCT01610102 ·Status: COMPLETED
-
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT05544864 ·Status: RECRUITING ·Phase: NA
-
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
NCT05477940 ·Status: UNKNOWN ·Phase: NA